Wednesday, December 24, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Is Almonty Industries Poised for a Major Share Price Breakout?

Robert Sasse by Robert Sasse
November 9, 2025
in Analysis, Commodities, Earnings, Penny Stocks
0
Almonty Stock
0
SHARES
143
VIEWS
Share on FacebookShare on Twitter

A significant shift in analyst sentiment is creating a stir around Almonty Industries. The tungsten producer’s stock received a notable upgrade over the weekend, with Wall Street Zen moving its rating from “Sell” to “Hold.” This reassessment signals a potential turning point for the company, driven by dramatic quarterly performance and strategic corporate developments.

Stunning Quarterly Turnaround

The Q3 2025 financial results reveal an extraordinary corporate transformation. Almonty reported net earnings of CAD 33.2 million, a remarkable reversal from the CAD 5.3 million loss recorded during the same quarter last year. This represents an approximately CAD 40 million positive swing that has exceeded even the most optimistic market expectations.

This dramatic improvement was primarily fueled by a non-cash gain of CAD 34.5 million resulting from the revaluation of warrant liabilities. Beyond this accounting adjustment, operational performance showed solid progress, with revenues climbing 28% to CAD 8.7 million. This growth was supported by stronger tungsten pricing and consistent production output from the company’s Panasqueira mine.

Should investors sell immediately? Or is it worth buying Almonty?

Strategic Expansion Initiatives

Almonty is executing a clear three-pronged growth strategy that positions it for future expansion:

  • North American Entry: The acquisition of the Gentung Browns Lake tungsten project in Montana for USD 9.75 million marks a strategic move into the United States and strengthens North American supply chains.
  • Portuguese Development: A major drilling program is underway at the Panasqueira mine, aimed at accessing new production zones and extending the asset’s operational lifespan.
  • Korean Commissioning: The company’s flagship Sangdong mine is in the final stages before production commencement, having now entered the ramp-up phase.

Revised Market Expectations

These strong results are forcing financial analysts to recalibrate their projections. B. Riley has substantially improved its 2025 earnings forecast, now projecting a loss of just $0.08 per share compared to its previous estimate of a $0.30 per share loss.

This follows earlier positive adjustments from other firms. In October, Oppenheimer dramatically increased its price target from $7.00 to $12.00 while maintaining an “Outperform” rating. DA Davidson followed suit, raising its target to $11.00 and reaffirming its “Buy” recommendation. The emerging consensus is clear: Almonty stands to benefit significantly from rising tungsten prices and its strategic positioning as a key non-Chinese supplier of the critical metal.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from December 24 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 24.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Inmune Bio Stock
Analysis

Inmune Bio Revises Warrant Terms in Strategic Financial Move

December 24, 2025
Meta Stock
AI & Quantum Computing

Regulatory Headwinds Challenge Meta’s AI Ambitions

December 24, 2025
Silber Preis Stock
Commodities

Silver Shatters Records as Supply Squeeze Intensifies

December 24, 2025
Next Post
DeFi Technologies Stock

DeFi Technologies Shares Hit 52-Week Low Amid Analyst Downgrades

Barrick Stock

Barrick's Strategic Shift Sets Stage for Crucial Earnings Report

Lynas Stock

Rare Earths Producer Lynas Defies Strong Output with Share Plunge

Recommended

Civista Bancshares Stock

A Tale of Two Signals: Insider Confidence Meets Analyst Caution at Civista Bancshares

4 months ago
Cisco Stock

Cisco Emerges as a Quiet Contender in the AI Infrastructure Race

2 months ago
Intel Stock

Government Backing Fails to Mask Intel’s Operational Struggles

4 months ago
Can ex-cons work at Walmart

Ikena Oncologys Q4 Earnings Report A Closer Look at Financial Performance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Almonty Industries Reaches Key Milestone with First Ore Delivery at Sangdong

VanEck’s BDC ETF Faces Net Asset Value Challenges

Public Storage Maintains Dividend Amid Operational Resilience

A Strategic Pivot at Nestlé: Organic Growth and Financial Discipline Take Center Stage

Solstice Advanced Materials Gains New Index Placements Amid Expansion Drive

Broadcom Leadership’s Stock Sale Draws Investor Scrutiny Amid AI Growth

Trending

Inmune Bio Stock
Analysis

Inmune Bio Revises Warrant Terms in Strategic Financial Move

by Andreas Sommer
December 24, 2025
0

In a strategic maneuver aimed at enhancing its financial flexibility, biotechnology firm Inmune Bio has modified the...

Meta Stock

Regulatory Headwinds Challenge Meta’s AI Ambitions

December 24, 2025
Silber Preis Stock

Silver Shatters Records as Supply Squeeze Intensifies

December 24, 2025
Almonty Stock

Almonty Industries Reaches Key Milestone with First Ore Delivery at Sangdong

December 24, 2025
VanEck BDC Income ETF Stock

VanEck’s BDC ETF Faces Net Asset Value Challenges

December 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Inmune Bio Revises Warrant Terms in Strategic Financial Move
  • Regulatory Headwinds Challenge Meta’s AI Ambitions
  • Silver Shatters Records as Supply Squeeze Intensifies

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com